Andres Gomez-Lievano
Education
Ph.D., applied mathematics for the life and social sciences, Arizona State University; M.Eng., industrial engineering, B.S., physics, Universidad de los Andes
Summary of Experience
Dr. Gomez-Lievano is an applied mathematician who specializes in advanced mathematical, computational, and statistical techniques to address challenges in the medical, social, and economic sciences. He has experience in areas including infectious diseases, rare conditions, neurological disorders, and vaccination strategies, and he has contributed to research on disease progression modeling, survival analysis, and the impact of public health interventions. Dr. Gomez-Lievano has experience in US Food and Drug Administration regulatory submissions of pivotal and confirmatory evidence. He uses data from clinical trials, administrative datasets, social security records, and epidemiological studies, employing techniques such as machine learning, Bayesian inference, causal analysis, and economic modeling. He has provided consulting services to local and national governments in Latin America and has participated in a wide range of policy projects designing strategies for economic development. Dr. Gomez-Lievano’s work has been published in several peer-reviewed journals and presented at international research conferences. Prior to joining Analysis Group, he was a researcher and Growth Lab associate at the Center for International Development at the Harvard Kennedy School.
-
Indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults
Current Medical Research and Opinion, 2025
2025Beck E, Georgieva M, Wang WJ, Gomez-Lievano A, Wang H, Gao Y, Kopel H, Bausch-Jurken M, Patterson-Lomba O, Mu F, Wu E, Van de Velde N
-
Descriptive characterization of ambulatory health states in Duchenne muscular dystrophy: Motor function trajectories and times to loss of ambulation
Journal of Neuromuscular Diseases, 2025
2025Muntoni F, Signorovitch J, Johnson M, Gomez-Lievano A, Posner N, Dorling P, Beaverson K, Alvir J, Mahn M, Ward SJ, Goemans N, Vandenborne K, Mercuri E, McDonald CM
-
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia
PLOS One, 2024
2024Daniels V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, Thobari JA, Durand N, Myers E
-
Assessing the long-term implications of age 9 initiation of HPV vaccination on series completion by age 13-15 in the US: projections from an age-structured vaccination model
Frontiers in Pediatrics, 2024
2024Saxena K, Patterson-Lomba O, Gomez-Lievano A, Zion A, Cunningham-Erves J, Kepka D
-
Structured Literature Review to Identify Human Papillomavirus's Natural History Parameters for Dynamic Population Models of Vaccine Impacts
Infectious Diseases and Therapy, 2024
2024Diakite I, Martins B, Owusu-Edusei K, Palmer C, Patterson-Lomba O, Gomez-Lievano A, Zion A, Simpson R, Daniels V, Elbasha E
-
Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Estimates from Real-World Data
The Journal of Prevention of Alzheimer's Disease, 2024
2024Chandler J, Done N, Desai U, Georgieva M, Gomez-Lievano A, Ye W, Zhao A, Eid D, Hilts A, Kirson N, Schilling T
-
Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons
Therapeutic Advances in Neurological Disorders, 2024
2024Paul D, Swallow E, Patterson-Lomba O, Branchcomb T, N'Dri L, Gomez-Lievano A, Liu J, Dua A, McGinley M
-
Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Findings from a Longitudinal Cohort Analysis
The Journal of Prevention of Alzheimers, 2024
2024Chandler J, Georgieva M, Desai U, Done N, Gomez-Lievano A, Ye W, Zhao A, Eid D, Hilts A, Kirson N, Schilling T
-
Comparative Efficacy and Safety of Ozanimod and Ponesimod for Relapsing Multiple Sclerosis: A Matching-Adjusted Indirect Comparison
Multiple Sclerosis and Related Disorders, 2023
2023Swallow E, Pham T, Patterson-Lomba O, Yin L, Gomez-Lievano A, Liu J, Tencer T, Gupte-Singh K
-
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom
Vaccine, 2022
2022Daniels V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, Saah A, Luxembourg A, Velicer C, Chen YT, Elbasha E
-
Estimating the drivers of urban economic complexity and their connection to economic performance
Royal Society Open Science, 2021
2021 -
Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States
Current Medical Research and Opinion, 2021
2021Saxena K, Marden JR, Carias C, Bhatti A, Patterson-Lomba O, Gomez-Lievano A, Yao L, Chen YT